Thomas K. Karikari (@tommykakari) 's Twitter Profile
Thomas K. Karikari

@tommykakari

ID: 294794533

calendar_today07-05-2011 19:49:51

267 Tweet

750 Followers

490 Following

Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

Two papers in two days for the #KarikariLab. Paper 1 gives guidelines for blood biobanking to support biomarker studies. Paper 2 reports association of plasma biomarkers with baseline cognition & longitudinal change in the population-based MYHAT study. Pitt Psychiatry Pitt's Alzheimer's Disease Research Center

Two papers in two days for the #KarikariLab. Paper 1 gives guidelines for blood biobanking to support biomarker studies. Paper 2 reports association of plasma biomarkers with baseline cognition &amp; longitudinal change in the population-based MYHAT study. <a href="/PittPsychiatry/">Pitt Psychiatry</a> <a href="/PittADRC/">Pitt's Alzheimer's Disease Research Center</a>
Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

- #Alzheimer blood biomarkers are great. - But many centers lack resources for cold storage of blood. - We examined if blood tubes with protease inhibitors can stabilize plasma biomarkers at room temp. onlinelibrary.wiley.com/doi/10.1111/jn…

- #Alzheimer blood biomarkers are great.        
                                         
- But many centers lack resources for cold storage of blood.   

- We examined if blood tubes with protease inhibitors can stabilize plasma biomarkers at room temp.

onlinelibrary.wiley.com/doi/10.1111/jn…
Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

Really excited to introduce everyone working in the #KarikariLab. I am fortunate to have an amazing group of scientists in the group dedicated to #ENDALZ. Pitt Psychiatry Pitt's Alzheimer's Disease Research Center Thread 👇🏾

Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

Delighted to share the latest manuscript from the #KarikariLab Karikari Lab, presenting a first independent evaluation of the new NULISA proteomic platform from AlamarBio. Access the paper here - …arneurodegeneration.biomedcentral.com/articles/10.11…

Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

Latest publication from the #KarikariLab Karikari Lab. We evalauted plasma p-tau217 and p-tau181 in a mild cogntively impaired (MCI) cohort recruited for a therapeutic trial. Where do plasma biomarkers fit in with current Alzheimer's disease detection? ajgponline.org/article/S1064-…

Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

Neuronal plasma biomarkers in acute ischemic stroke. A masterpiece led by Fernando Gonzalez and our Norwegian collaborators. journals.sagepub.com/doi/10.1177/02…

Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

Delighted to have been recognized as a "Highly Cited Researcher" in the list released by Clarivate today. Thank you to everyone who has contributed to my career thus far.

Delighted to have been recognized as a "Highly Cited Researcher" in the list released by Clarivate today. 

Thank you to everyone who has contributed to my career thus far.
UPMC (@upmcnews) 's Twitter Profile Photo

Longtime #Alzheimers physician and expert Oscar Lopez has joined the Alzheimer's Association board of directors. The news marks the first time a Pittsburgh-based scientist and researcher will be on the board. Full story via Hanna Webster @hannamwebster.bsky.social & Pittsburgh Post-Gazette 👇 post-gazette.com/news/health/20…

Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

Check out the latest preprint from the Karikari Lab. We evaluated blood 🩸 assays on the NULISA proteomic platform from AlamarBio to detect brain amyloid pathology and neurodegeneration in the ethnically diverse HCP cohort led by @AnnCohenWilson2. Coming soon in Alzheimer's & Dementia Journals.

Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

From the MYHAT-Neuroimaging study comes this masterpeice led by Andrea Weinstein, published in the Journal of Alzheimer's Disease. Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementia journals.sagepub.com/doi/10.1177/13…

Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

Pleased to share the last publication from the Karikari Lab in 2025. Thank you to all our friends, collaborators, allies, and colleagues who continue to make our stay in Pittsburgh delightful and our work impactful. medrxiv.org/content/10.110…

Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

The NIH funded Brain CHEC study aims to deepen relationships with the Black community in Pittsburgh, toward understanding root cause(s) of high dementia burden among Black individuals. With @AnnCohenWilson2, Jen Lingler, Dara Mendez & other amazing folks. health.pitt.edu/news/encouragi…

Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

In Nature Medicine, we show: 1. P-tau262 & P-tau356 as markers of pre-tangle tau pathology; 2. Identify a core region that defines soluble tau assemblies (STA); and 3. Validate CSF STA assay in autopsy & tau PET cohorts. Congrats to all coauthors! nature.com/articles/s4159…

In <a href="/NatureMedicine/">Nature Medicine</a>, we show: 
1. P-tau262 &amp; P-tau356 as markers of pre-tangle tau pathology; 
2. Identify a core region that defines soluble tau assemblies (STA); and 
3. Validate CSF STA assay in autopsy &amp; tau PET cohorts. 
Congrats to all coauthors! nature.com/articles/s4159…
Thomas K. Karikari (@tommykakari) 's Twitter Profile Photo

Thank you Jerome Staal and team for the fast and fair review process. We are confident that these findings will enable early and reliable detection of emerging tau aggregate pathology before mature tangles are formed. nature.com/articles/s4159…